TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12847152

Group type: EXPERIMENTAL
Intervention: [11C]DTBZ binding in the striatum
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: [123I]IBVM binding in the thalamus
Number of subjects: 13
Study: 10875180

Group type: EXPERIMENTAL
Intervention: Electronic mood device (EMD)
Number of subjects: 0
Study: 9167019

Group type: EXPERIMENTAL
Intervention: Classical, low-pressure, whole-leg boots system
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Novel, high-pressure, plantar compression system
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both pneumatic compression devices under induced venous leg stasis
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both pneumatic compression devices
Number of subjects: 10
Study: 8193732

Group type: EXPERIMENTAL
Intervention: Felodipine 5-20 mg orally once daily for 8 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Enalapril 5-20 mg orally once daily for 8 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 3082683

Group type: EXPERIMENTAL
Intervention: CO2 laser surgery
Number of subjects: 63

Group type: COMPARATOR
Intervention: Electrosurgery (microdiathermy needle)
Number of subjects: 63
Study: 31965734

Group type: EXPERIMENTAL
Intervention: Trauma-focused therapy (TFT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Assertiveness training
Number of subjects: 49
Study: 31350967

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50,000 IU weekly for 2 months)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 29781787

Group type: EXPERIMENTAL
Intervention: Post-operative cefazolin for 23 hours
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 26179985

Group type: EXPERIMENTAL
Intervention: Active treatment group received a single shockwave treatment with 1000 impulses at 0.19-0.23 mJ/mm²
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo group treated with a deactivated shockwave applicator but acoustic sham
Number of subjects: 72
Study: 25163030

Group type: EXPERIMENTAL
Intervention: Vitamin B6 supplement (daily)
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Care as usual (without placebo)
Number of subjects: 1011
Study: 22689712

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bepridil
Number of subjects: 40
Study: 19816204

Group type: EXPERIMENTAL
Intervention: Low propofol (4 mg/kg/h)
Number of subjects: 34

Group type: COMPARATOR
Intervention: High propofol (6 mg/kg/h)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both propofol concentrations
Number of subjects: 34
Study: 19061063

Group type: EXPERIMENTAL
Intervention: 12-week structured exercise programme focusing on cardio respiratory endurance, strength and flexibility training
Number of subjects: 20
Study: 16052090

Group type: EXPERIMENTAL
Intervention: Ultrasonography for assessing facial lipoatrophy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12091806

Group type: EXPERIMENTAL
Intervention: HBOC-201 (Hemopure; Biopure Corporation, Cambridge, Mass)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: HBOC-201
Number of subjects: 98

Group type: COMPARATOR
Intervention: Red blood cell units
Number of subjects: 98
Study: 10501335

Group type: COMPARATOR
Intervention: Gray scale MCE alone
Number of subjects: 31

Group type: COMPARATOR
Intervention: MCE combined with baseline 2D
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Subtraction and color coding of triggered images
Number of subjects: 31

Group type: COMPARATOR
Intervention: Gray scale MCE with baseline comparison
Number of subjects: 31

Group type: COMPARATOR
Intervention: Gray scale MCE without baseline comparison
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Post processing of continuous images
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Colorized images
Number of subjects: 31
Study: 8946597

Group type: EXPERIMENTAL
Intervention: SLE patients with reduced lymphocyte counts
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CD4+ T-PBL in SLE patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CD8+ T-PBL in SLE patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Transient CD8+ T-PBL in SLE patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High anti-CL in SLE patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Loss of naive and increase of transient CD8+ T-PBL in SLE patients
Number of subjects: 29
Study: 1342326

Group type: EXPERIMENTAL
Intervention: Lottery ticket offer (intervention group)
Number of subjects: 954

Group type: COMPARATOR
Intervention: No lottery ticket offer (control group)
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: Overall response rates
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: Percent of urban dwellers
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 954
Study: 12267105

Group type: EXPERIMENTAL
Intervention: IUDs with strings
Number of subjects: 300

Group type: COMPARATOR
Intervention: IUDs without strings
Number of subjects: 300
Study: 30614153

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sevoflurane (group S)
Number of subjects: 73
Study: 29216559

Group type: EXPERIMENTAL
Intervention: Ethanol stove
Number of subjects: 324

Group type: COMPARATOR
Intervention: Control (kerosene/firewood stove)
Number of subjects: 324
Study: 26614017

Group type: EXPERIMENTAL
Intervention: ProTaper Next (Dentsply Tulsa Dental Specialties)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: WaveOne (Dentsply Tulsa Dental Specialties)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Reciproc (VDW, Munich, Germany)
Number of subjects: 210
Study: 23385306

Group type: EXPERIMENTAL
Intervention: Nursing consultations
Number of subjects: 287

Group type: COMPARATOR
Intervention: Shared care
Number of subjects: 287

Group type: COMPARATOR
Intervention: Rheumatologist consultations
Number of subjects: 287
Study: 22595584

Group type: EXPERIMENTAL
Intervention: Near Needle Holder (NNH)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cook Dieckmann manual IO needle
Number of subjects: 32
Study: 20555369

Group type: EXPERIMENTAL
Intervention: Soy milk (3 servings per day for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Dairy milk (3 servings per day for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Eccentric exercise bout
Number of subjects: 31
Study: 18630532

Group type: EXPERIMENTAL
Intervention: Moxibustion on heat-sensitive acupoints
Number of subjects: 107

Group type: COMPARATOR
Intervention: Acupuncture, cupping, and TDP (Control)
Number of subjects: 107
Study: 16187808

Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) system for daily reports of cigarette use.
Number of subjects: 381

Group type: COMPARATOR
Intervention: Timeline Follow-Back (TLFB) method for daily reports of cigarette use.
Number of subjects: 381
Study: 12042274

Group type: EXPERIMENTAL
Intervention: Day 5 inhibin B >400 pg/ml
Number of subjects: 54

Group type: COMPARATOR
Intervention: Day 5 inhibin B <400 pg/ml
Number of subjects: 54
Study: 10365802

Group type: EXPERIMENTAL
Intervention: Interferon therapy
Number of subjects: 26
Study: 8746902

Group type: EXPERIMENTAL
Intervention: Primary coronary angioplasty
Number of subjects: 301

Group type: COMPARATOR
Intervention: Intravenous streptokinase therapy
Number of subjects: 301
Study: 1791163

Group type: EXPERIMENTAL
Intervention: Zinc citrate (1%, w/w) and Triclosan (0.2%, w/w) dentifrice
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard fluoride dentifrice
Number of subjects: 102
Study: 6350616

Group type: EXPERIMENTAL
Intervention: Ceftazidime 250 mg administered intramuscularly every 12 hours
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ceftazidime 500 mg administered intramuscularly every 12 hours
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ceftazidime 1000 mg administered intramuscularly every 12 hours
Number of subjects: 60
Study: 30868641

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Nutritional training (NT)
Number of subjects: 73
Study: 30125034

Group type: EXPERIMENTAL
Intervention: Total Disk Replacement (TDR)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Anterior Cervical Diskectomy and Fusion (ACDF)
Number of subjects: 96
Study: 26847071

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Minocycline (excluding patients dying within one day of hospitalization)
Number of subjects: 281
Study: 25600559

Group type: EXPERIMENTAL
Intervention: Uncoated monofilament polypropylene mesh
Number of subjects: 48

Group type: COMPARATOR
Intervention: Polypropylene‐polyurethane double surface mesh
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 22813476

Group type: EXPERIMENTAL
Intervention: Transitions Clinic (primary care‐based care management program with a community health worker)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Expedited primary care
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 20004036

Group type: EXPERIMENTAL
Intervention: Known diabetes
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: New diabetes
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Taking anti-hypertensive medication
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Impaired glucose tolerance (IGT) / Impaired fasting glucose (IFG)
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 1453
Study: 17974536

Group type: EXPERIMENTAL
Intervention: Long-term retention (mean period 9.65 years)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Short-term retention (3-6 months)
Number of subjects: 64
Study: 16316359

Group type: EXPERIMENTAL
Intervention: Oral paricalcitol (mean dose 9.5 microg/week)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Oral paricalcitol
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 12115318

Group type: EXPERIMENTAL
Intervention: HA‐HAase test
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: BTA‐Stat test
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: HA‐HAase test in DOE workers
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: BTA‐Stat test in DOE workers
Number of subjects: 70
Study: 9689834

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2a and compression
Number of subjects: 4

Group type: COMPARATOR
Intervention: Steroids (previous treatment)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 4
Study: 8075780

Group type: EXPERIMENTAL
Intervention: High-dose (HD) carbimazole 60 mg plus thyroxine 100-150 micrograms daily
Number of subjects: 70

Group type: COMPARATOR
Intervention: Titration-dose (TD) carbimazole
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High-dose (HD) and Titration-dose (TD) regimens
Number of subjects: 70
Study: 2782339

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31685037

Group type: EXPERIMENTAL
Intervention: Whole-grain consumption (dietary advice to obtain at least half of cereal servings from whole-grain foods)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Whole-grain consumption
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (usual cereals)
Number of subjects: 112
Study: 31544547

Group type: EXPERIMENTAL
Intervention: History of transcatheter arterial chemoembolization (TACE) treatment
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Tumor location
Number of subjects: 58

Group type: COMPARATOR
Intervention: History of biliary manipulation
Number of subjects: 58
Study: 29221779

Group type: EXPERIMENTAL
Intervention: 9-g sodium oxybate (SXB)/nightly
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 200-600 mg/d modafinil
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: SXB + modafinil
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: SXB
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Modafinil alone
Number of subjects: 155
Study: 26011257

Group type: EXPERIMENTAL
Intervention: FVOOT (functional virgin olive oil with thyme)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: FVOOT
Number of subjects: 33

Group type: COMPARATOR
Intervention: VOO
Number of subjects: 33

Group type: COMPARATOR
Intervention: FVOO
Number of subjects: 33
Study: 23307617

Group type: EXPERIMENTAL
Intervention: Whole grain rye bread (RB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Refined wheat bread (WB)
Number of subjects: 20
Study: 21316259

Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB) group (n=20) - 15 ml of ropivacaine 0.2% every 6h combined with endovenous metamizol (1g)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alternate NSAIDs group (AN) (n=20) - Paracetamol (1g) combined with metamizol (1g) every 6h
Number of subjects: 40
Study: 20055118

Group type: EXPERIMENTAL
Intervention: 150 mg b.i.d.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 300 mg q.d.
Number of subjects: 106
Study: 16673060

Group type: EXPERIMENTAL
Intervention: Epoetin beta
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 15513743

Group type: EXPERIMENTAL
Intervention: Hand-held device (Tremorometer) for quantifying tremor
Number of subjects: 242
Study: 11752357

Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg every morning) before ibuprofen (400 mg every morning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg every morning) before acetaminophen (1000 mg every morning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg every morning) before rofecoxib (25 mg every morning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin before ibuprofen (400 mg three times a day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin before delayed-release diclofenac (75 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin (81 mg every morning) after ibuprofen (400 mg every morning)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple daily doses of ibuprofen before aspirin
Number of subjects: 0
Study: 9407270

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) for OCD, consisting of 12 weekly sessions.
Number of subjects: 52
Study: 8288295

Group type: EXPERIMENTAL
Intervention: Nurse-client transactional intervention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no transactional intervention)
Number of subjects: 51
Study: 3814463

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sulindac (200 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (100 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Piretanide (6 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Naproxen (500 mg) with Hydrochlorothiazide (100 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Naproxen (500 mg) with Piretanide (6 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sulindac (200 mg) with Hydrochlorothiazide (100 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sulindac (200 mg) with Piretanide (6 mg)
Number of subjects: 5
Study: 29538682

Group type: EXPERIMENTAL
Intervention: Single vaccination with quadrivalent inactivated influenza vaccine (QIV)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Booster vaccination with quadrivalent inactivated influenza vaccine (QIV)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Infliximab therapy
Number of subjects: 132
Study: 28018112

Group type: EXPERIMENTAL
Intervention: Capsaicin infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Repeated capsaicin infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acute capsaicin infusion
Number of subjects: 10
Study: 24659021

Group type: EXPERIMENTAL
Intervention: Lenalidomide (10 mg × 7 days) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lenalidomide (10 mg × 7 days) with digoxin (0.5 mg on Day 5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide (25 mg single dose) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quinidine (300-600 mg twice-daily × 5 days) plus lenalidomide (on Day 4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temsirolimus (25 mg single dose) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide plus temsirolimus (25 mg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 0
Study: 22572767

Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Donepezil 10 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day with memantine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day without memantine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Donepezil 10 mg/day with memantine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Donepezil 10 mg/day without memantine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study: 19470086

Group type: EXPERIMENTAL
Intervention: Low protein/low glycaemic index diet
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Low protein/high glycaemic index diet
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: High protein/low glycaemic index diet
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: High protein/high glycaemic index diet
Number of subjects: 891

Group type: COMPARATOR
Intervention: Control (national dietary guidelines)
Number of subjects: 891
Study: 18425522

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA) injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Arteriovenous (AV) sheathotomy
Number of subjects: 40
Study: 16187470

Group type: EXPERIMENTAL
Intervention: Intravenous morphine at 0.1 mg/kg
Number of subjects: 119
Study: 14605954

Group type: EXPERIMENTAL
Intervention: Micronized flavonoid fractions (MFF) for 1 week
Number of subjects: 112
Study: 10793494

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic lobectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional lobectomy via open thoracotomy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Video-assisted thoracoscopic lobectomy and Conventional lobectomy)
Number of subjects: 20
Study: 8610616

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0
Study: 1947593

Group type: COMPARATOR
Intervention: 0-hr nap
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 2-hr nap
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 4-hr nap
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 8-hr nap
Number of subjects: 104
Study: 6849725

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 75

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 75
Study: 30456511

Group type: EXPERIMENTAL
Intervention: Captivator device
Number of subjects: 11

Group type: COMPARATOR
Intervention: Duette device
Number of subjects: 11
Study: 28688170

Group type: EXPERIMENTAL
Intervention: Orthopedic reinforced gloves
Number of subjects: 193

Group type: COMPARATOR
Intervention: Double standard gloves
Number of subjects: 193
Study: 25837212

Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LSM) with 80g pistachios daily for 3 months
Number of subjects: 60
Study: 24014828

Group type: EXPERIMENTAL
Intervention: CRT ON
Number of subjects: 608

Group type: COMPARATOR
Intervention: CRT
Number of subjects: 608
Study: 21724564

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (loading dose 1 g over 10 minutes, then infusion of 1 g over 8 hours)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 270
Study: 20012799

Group type: EXPERIMENTAL
Intervention: Two servings of dairy products/day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Three servings of dairy products/day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Four servings of dairy products/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Calorie restricted diet (control group)
Number of subjects: 120
Study: 17704496

Group type: EXPERIMENTAL
Intervention: Endarterectomy
Number of subjects: 527

Group type: COMPARATOR
Intervention: Stenting
Number of subjects: 527
Study: 15848673

Group type: EXPERIMENTAL
Intervention: Complete steroid avoidance (standard therapy without steroid induction/maintenance)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard therapy (tacrolimus, mycophenolate mofetil, steroid induction/maintenance)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Complete steroid avoidance
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 72
Study: 11999667

Group type: EXPERIMENTAL
Intervention: BH4 (1 mg/min)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 28
Study: 10464738

Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 8672316

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 1 ml kg‐1 with ketamine 0.5 mg kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.25% bupivacaine 1 ml kg‐1 with clonidine 2 micrograms kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 1 ml kg‐1 with adrenaline 5 micrograms ml‐1 (1/200,000)
Number of subjects: 60
Study: 2189288

Group type: COMPARATOR
Intervention: CMF
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CMF + T
Number of subjects: 49
Study: 23973

Group type: EXPERIMENTAL
Intervention: Oxypertine 30 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxypertine 60 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study: 29799307

Group type: EXPERIMENTAL
Intervention: Triflo II (TF)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing (DB)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Water pressure threshold device (BreatheMAX; BM)
Number of subjects: 14